Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Year End Trading Update

Today 07:00

RNS Number : 0169M
Sabien Technology Group PLC
13 July 2026
 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation.

13 July 2026

Sabien Technology Group plc

("Sabien", the "Company" or the "Group")

Year End Trading Update

 

Sabien (AIM: SNT), a provider of energy efficiency technologies through its M2G intelligent boiler optimisation platform, provides a trading update ahead of the publication of its audited results for the year ended 30 June 2026 ("FY2026").

During FY2026 the Company focused on transforming Sabien into a higher-margin technology business centred on its M2G Cloud Connect platform, whilst strengthening its balance sheet and evaluating strategic opportunities to accelerate long-term shareholder value.

Trading

The M2G platform enables operators of commercial gas boilers to reduce energy consumption and carbon emissions by between 10% and 30%, typically delivering customers with a payback period of less than twelve months.

Customer orders received during FY2026 totalled over £908,000 (FY2025: £948,053), demonstrating resilient customer demand despite a challenging capital expenditure environment.

Revenue recognised during FY2026 is expected to be over £746,000 (FY2025: £846,015), subject to completion of the audit process.

Revenue recognised during the second half of the financial year principally reflected the timing of customer installation programmes, with a number of orders received in the period carried forward into FY2027 revenue.

The Company enters FY2027 with confirmed customer orders of over £196,000, compared with £59,453 at the beginning of FY2026, providing materially improved revenue visibility entering the new financial year.

Balance Sheet

During the year the Company completed several initiatives to strengthen its balance sheet, including the repayment of one of the loans previously provided by Parris Group Limited, as announced on 2 June 2026.

The Board believes these actions have materially improved the Company's financial position and provide a stronger platform from which to execute its commercial strategy.

Strategic Review

As announced on 21 May 2026, the Board commenced a review of strategic initiatives intended to accelerate long-term shareholder value.

The review has included discussions regarding potential strategic investment and commercial partnership opportunities intended to accelerate deployment of the M2G platform and support the Company's long-term growth strategy.

Those discussions remain ongoing. No agreement has been reached and there can be no certainty that any transaction will ultimately proceed.

The Board is evaluating alternative structures and will only pursue a transaction where it believes the commercial terms appropriately reflect the long-term strategic value of the Company, maintain an appropriate balance of commercial risk and reward, and are demonstrably in the best interests of all shareholders.

The strategic review has reinforced the Board's confidence in the long-term value of the Company's technology and in its ability to create shareholder value through continued independent execution, commercial partnerships or broader strategic relationships.

Accordingly, the Board's priorities remain focused on:

· expanding commercial routes to market;

· completing the migration of the M2G platform to the EVO architecture;

· improving operational leverage and cash generation; and

· maintaining disciplined capital allocation to maximise long-term shareholder value.

COF / b.grn

The Board continues to review the Company's investment in b.grn Group Limited and associated commercial arrangements relating to City Oil Field ("COF").

Whilst the Company's principal strategic focus remains the growth of its M2G business, the Board believes it is appropriate to preserve strategic flexibility in relation to its COF-related interests whilst its review continues.

Accordingly, the Board believes it is in shareholders' best interests to complete its review only once it has sufficient clarity to determine the long-term structure that best maximises shareholder value.

Richard Parris, Executive Chairman, commented:

"The past year has been one of disciplined execution. We have strengthened the Company's balance sheet, maintained resilient customer demand and entered FY2027 with a significantly stronger opening order book.

Over recent months the Board has carefully evaluated various strategic alternatives capable of accelerating shareholder value. Our responsibility is to ensure that any strategic transaction appropriately reflects the long-term strategic value of the Company, maintains an appropriate balance of commercial risk and reward, and delivers a superior outcome for shareholders compared with continued disciplined execution of our strategy.

Our priorities remain unchanged. We will continue to broaden our commercial routes to market, complete the migration of the M2G platform to the EVO architecture, improve operational efficiency and maintain disciplined capital allocation as we build a stronger and more scalable business.

Sabien today is a stronger business than it was twelve months ago. We have a stronger balance sheet, greater visibility entering the new financial year and a clearer strategic focus. That disciplined approach also extends to preserving strategic flexibility where the Board believes doing so has the potential to maximise long-term shareholder value."

For further information

Sabien Technology Group plc

Richard Parris, Executive Chairman

+44 (0)20 7993 3700

investors@sabien.com

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

+44 (0)20 3328 5656

AlbR Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 (0)20 7469 0930

About Sabien Technology Group plc

Sabien Technology Group plc develops technologies that help organisations reduce energy consumption, lower carbon emissions and improve building efficiency through intelligent energy optimisation technologies.

The Company holds the London Stock Exchange's Green Economy Mark, recognising listed companies deriving more than 50% of revenues from products and services supporting the global green economy.

Website: www.sabien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRTMFTMTABBAF
Date   Source Headline
13th Jul 20267:00 amRNSYear End Trading Update
30th Jun 20265:00 pmRNSTotal Voting Rights
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.